MAPT and Alzheimer disease: Alzheimer’s Disease (AD) is a neurodegenerative disorder characterized by the presence of neurofibrillary tangles, amyloid-β plaques, synaptic loss, and abnormal Tau proteins in the brain (Ginsberg et al., 1995; Guan et al., 1999; Han et al., 2001).